LOM Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
LOM Asset Management's NVO Position: Q1 2026 in Review
LOM Asset Management reduced its Novo Nordisk (NVO) stake by 0.61% in Q1 2026, selling an estimated $4.74K and leaving 16,350 shares worth $601K. The position accounts for 0.17% of the portfolio, ranked #119.
LOM Asset Management first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $915K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- LOM Asset Management held 16,350 shares of Novo Nordisk worth $601K as of Q1 2026.
- LOM Asset Management sold 100 Novo Nordisk shares in Q1 2026, an estimated $4.74K.
- Novo Nordisk made up 0.17% of LOM Asset Management's portfolio in Q1 2026, its #119 holding.
- LOM Asset Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
- LOM Asset Management's Novo Nordisk position peaked at $915K in Q3 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on LOM Asset Management's 13F filing for Q1 2026, filed 5 May 2026.